DrugPatentWatch Database Preview
Ingenus Pharms Llc Company Profile
What is the competitive landscape for INGENUS PHARMS LLC, and what generic and branded alternatives to INGENUS PHARMS LLC drugs are available?
INGENUS PHARMS LLC has seventeen approved drugs.
Summary for Ingenus Pharms Llc
| US Patents: | 0 |
| Tradenames: | 17 |
| Ingredients: | 17 |
| NDAs: | 17 |
Drugs and US Patents for Ingenus Pharms Llc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ingenus Pharms Llc | CABERGOLINE | cabergoline | TABLET;ORAL | 204735-001 | Aug 1, 2018 | AB | RX | No | No | See Pricing | See Pricing | ||||
| Ingenus Pharms Llc | FENOFIBRATE (MICRONIZED) | fenofibrate | CAPSULE;ORAL | 207564-002 | Apr 19, 2019 | AB | RX | No | No | See Pricing | See Pricing | ||||
| Ingenus Pharms Llc | LEUCOVORIN CALCIUM | leucovorin calcium | INJECTABLE;INJECTION | 210917-001 | Nov 23, 2018 | AP | RX | No | No | See Pricing | See Pricing | ||||
| Ingenus Pharms Llc | CARBOPLATIN | carboplatin | INJECTABLE;INTRAVENOUS | 208487-001 | Apr 26, 2017 | AP | RX | No | No | See Pricing | See Pricing | ||||
| Ingenus Pharms Llc | CARBOPLATIN | carboplatin | INJECTABLE;INTRAVENOUS | 208487-003 | Apr 26, 2017 | AP | RX | No | No | See Pricing | See Pricing | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
